AI Takes on Cancer, InvestFest’s Identity Crisis & The Discipline to Protect Deep Work

AI is moving from hype to tangible breakthroughs—and medicine may be where it matters most. Dre, Rodney, and Brylan examine how AI and mRNA could accelerate personalized cancer treatments, the barriers that still stand between innovation and access, and what the next era of drug discovery could look like.They also unpack the controversy around InvestFest and its relationship with its core audience, then turn to the discipline required to protect deep-work hours, pace yourself for long-term success, and communicate strategically when the stakes are high.